The CRC Blueprint

My scientific approach to my own cancer – shared with you.

Recruiting now

ICE Study: Combination of Irinotecan Plus Cetuximab and Envafolimab as a Rechallenge Regimen in mCRC

Phase 2 · 60 people · 1 site in China · Recruiting now

October 20, 2026
Liver Transplantation for Non-resectable Colorectal Liver Metastases: Translational Research

Not phased · 35 people · 1 site in Spain · Recruiting now

October 20, 2026
A Study of ASP1002 in Adults for Treatment of Solid Tumors

Phase 1 · 798 people · 15 sites in United States · Recruiting now

October 20, 2026
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers

Not phased · 28 people · 2 sites in United States · Recruiting now

October 20, 2026
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

Phase 1 · 48 people · 8 sites in United States · Recruiting now

October 20, 2026
A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumor and Other Solid Tumor

Phase 1 · 96 people · 6 sites in China · Recruiting now

October 20, 2026
Clinical Utility of ctDNA in Detecting Resistance Mechanisms and Delivering Precision Medicine to Cancer Patients

Not phased · 100 people · 1 site in United Kingdom · Recruiting now

October 20, 2026
Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Metastasis

Early phase 1 · 10 people · 2 sites in United States · Recruiting now

October 20, 2026
Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors

Phase 1 · 60 people · 7 sites in Australia · Recruiting now

October 20, 2026
A Study of DEG6498 in Participants With Solid Tumors

Phase 1 · 100 people · 3 sites in China · Recruiting now

October 20, 2026